TECHNOLOGY FOCUS - PHARMACEUTICALS - Preferred Composition: The foamable composition comprising thyme oil (0.016 wt./vol.%), origanum oil (0.016 wt./vol.%), botanical thymol crystals (0.032% wt./vol.%), alkyl polyglucoside surfactant (3.0 vol./vol.%), copper PCA (0.008 wt./vol.%), water to 100%. The composition further comprises origanum oil, thymol crystals, at least one of fragrance, antioxidant, humectant, and co-surfactant. The composition further comprises at least one of white tea, citric acid, sodium citrate, co-surfactant, natural moisturizer, and aloe vera. Preferred Components: The antimicrobial amount of thyme oil is 0.01-0.2 wt./vol.%. The origanum oil is present in an amount of 0.01-0.2 wt./vol.%. The thymol crystals are present in an amount of 0.01-0.5 wt./vol.%. The fragrance is selected from blood orange, vanilla, lavender, ginger, bergamot, spearmint, and lime. The antioxidant is white tea extract. The source of divalent copper ion is copper peptide complex. The copper peptide complex is copper pyrrolidone carboxylic acid (PCA). The surfactant is anionic or nonionic surfactant. The surfactant is selected from alkyl polyglucoside, sodium lauryl sulfate, and sodium laureth sulfate. Preferred Method: In method (M1), the surface comprises mammalian skin. The mammalian skin comprises human skin. The foamable composition is applied to open wound. The exposure time is at least hour (preferably 15 seconds, especially 5 minutes). The foamable composition is applied at least once a day. ACTIVITY - Antibacterial; Antimicrobial; Dermatological; Antiinflammatory; Analgesic; Antiseborrheic; Fungicide. The efficacy of foamable composition (A1) was evaluated for antibacterial activity using time kill test assay against Community Acquired Methicillin Resistant Staphylococcus aureus. The foamable composition (A1) showed 99.9% reduction of Community Acquired Methicillin Resistant Staphylococcus aureus survivors after 15 second exposure, 99.999% reduction after 300 second exposure when tested at ambient temperature (21 degrees C).    MECHANISM OF ACTION - None given.    ADMINISTRATION - Administration is topical (claimed). No dosage details given.    EXAMPLE - A foamable composition (A1) comprising thymol crystals (0.032 wt./vol.%), thyme oil (0.016 wt./vol.%), origanum oil (0.016 wt./vol.%), fragrance (0.6 vol./vol.%), blood orange (0.1), vanilla (0.5), Suga Nate 100 (RTM: alkyl polyglucoside sulfonate polymers) (3 vol./vol.%), sodium lauryl sulfate (5 vol./vol.%), white tea (0.01 vol./vol.%), citric acid (0.21 wt./vol.%), sodium citrate (0.4 wt./vol.%), Cromosist O-25 (RTM: hydrolyzed oats) (0.1 vol./vol.%), aloe vera extract (0.25 vol./vol.%), copper pyrrolidone carboxylic acid (PCA) (0.008 wt./vol.%), deionized water (90.358 vol./vol.%) was prepared.